Trials / Conditions / Carcinoma, Non-Small-Cell Lung (NSCLC)
Carcinoma, Non-Small-Cell Lung (NSCLC)
7 registered clinical trials studyying Carcinoma, Non-Small-Cell Lung (NSCLC) — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanc NCT07489066 | Pfizer | Phase 2 |
| Recruiting | Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemother NCT07222566 | Pfizer | Phase 3 |
| Not Yet Recruiting | Primary Radiotherapy In MEtastatic Lung Cancer NCT07135882 | Trans Tasman Radiation Oncology Group | Phase 3 |
| Recruiting | This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizuma NCT06758401 | Pfizer | Phase 3 |
| Recruiting | Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Ass NCT06833229 | Centre Antoine Lacassagne | — |
| Completed | Locally Advanced NSCLC Hyperfractionated RT NCT03128008 | Duke University | Phase 2 |
| Completed | Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer NCT00735904 | Pfizer | Phase 2 |